These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 14716844

  • 1. Enhancement of migration and invasion of hepatoma cells via a Rho GTPase signaling pathway.
    Wang DS, Dou KF, Li KZ, Song ZS.
    World J Gastroenterol; 2004 Jan 15; 10(2):299-302. PubMed ID: 14716844
    [Abstract] [Full Text] [Related]

  • 2. Lysophosphatidic acid induces focal adhesion assembly through Rho/Rho-associated kinase pathway in human ovarian cancer cells.
    Sawada K, Morishige Ki, Tahara M, Ikebuchi Y, Kawagishi R, Tasaka K, Murata Y.
    Gynecol Oncol; 2002 Dec 15; 87(3):252-9. PubMed ID: 12468322
    [Abstract] [Full Text] [Related]

  • 3. Y-27632, an inhibitor of rho-associated protein kinase, suppresses tumor cell invasion via regulation of focal adhesion and focal adhesion kinase.
    Imamura F, Mukai M, Ayaki M, Akedo H.
    Jpn J Cancer Res; 2000 Aug 15; 91(8):811-6. PubMed ID: 10965022
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of intrahepatic metastasis of human hepatocellular carcinoma by Rho-associated protein kinase inhibitor Y-27632.
    Takamura M, Sakamoto M, Genda T, Ichida T, Asakura H, Hirohashi S.
    Hepatology; 2001 Mar 15; 33(3):577-81. PubMed ID: 11230737
    [Abstract] [Full Text] [Related]

  • 6. Rho-associated kinase inhibitor reduces tumor recurrence after liver transplantation in a rat hepatoma model.
    Ogawa T, Tashiro H, Miyata Y, Ushitora Y, Fudaba Y, Kobayashi T, Arihiro K, Okajima M, Asahara T.
    Am J Transplant; 2007 Feb 15; 7(2):347-55. PubMed ID: 17229077
    [Abstract] [Full Text] [Related]

  • 7. Rho-Rho kinase is involved in smooth muscle cell migration through myosin light chain phosphorylation-dependent and independent pathways.
    Ai S, Kuzuya M, Koike T, Asai T, Kanda S, Maeda K, Shibata T, Iguchi A.
    Atherosclerosis; 2001 Apr 15; 155(2):321-7. PubMed ID: 11254902
    [Abstract] [Full Text] [Related]

  • 8. The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion.
    Jeong KJ, Park SY, Cho KH, Sohn JS, Lee J, Kim YK, Kang J, Park CG, Han JW, Lee HY.
    Oncogene; 2012 Sep 27; 31(39):4279-89. PubMed ID: 22249252
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of Rho-kinase affects astrocytoma morphology, motility, and invasion through activation of Rac1.
    Salhia B, Rutten F, Nakada M, Beaudry C, Berens M, Kwan A, Rutka JT.
    Cancer Res; 2005 Oct 01; 65(19):8792-800. PubMed ID: 16204049
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Enhancement of invasion of hepatocellular carcinoma cells by lysophosphatidic acid through Rho signal transduction pathway].
    Wang DS, Dou KF, Li KZ, Song ZS, Zhao QC.
    Zhonghua Yi Xue Za Zhi; 2006 Feb 14; 86(6):399-402. PubMed ID: 16677550
    [Abstract] [Full Text] [Related]

  • 12. Cell motility mediated by rho and Rho-associated protein kinase plays a critical role in intrahepatic metastasis of human hepatocellular carcinoma.
    Genda T, Sakamoto M, Ichida T, Asakura H, Kojiro M, Narumiya S, Hirohashi S.
    Hepatology; 1999 Oct 14; 30(4):1027-36. PubMed ID: 10498656
    [Abstract] [Full Text] [Related]

  • 13. [Rho-mediated signal transduction and its physiological roles].
    Ishizaki T.
    Nihon Yakurigaku Zasshi; 2003 Mar 14; 121(3):153-62. PubMed ID: 12673949
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. RhoC mediates invasion and migration of CaSki cells through the Rho-associated serine-threonine protein kinase 1 signaling pathway.
    Chen R, Cheng Y, Zhang Y, Li Z, Geng L.
    Int J Gynecol Cancer; 2014 Feb 14; 24(2):184-91. PubMed ID: 24457551
    [Abstract] [Full Text] [Related]

  • 16. E1AF/PEA3 activates the Rho/Rho-associated kinase pathway to increase the malignancy potential of non-small-cell lung cancer cells.
    Hakuma N, Kinoshita I, Shimizu Y, Yamazaki K, Yoshida K, Nishimura M, Dosaka-Akita H.
    Cancer Res; 2005 Dec 01; 65(23):10776-82. PubMed ID: 16322223
    [Abstract] [Full Text] [Related]

  • 17. The G protein-coupled receptor S1P2 regulates Rho/Rho kinase pathway to inhibit tumor cell migration.
    Lepley D, Paik JH, Hla T, Ferrer F.
    Cancer Res; 2005 May 01; 65(9):3788-95. PubMed ID: 15867375
    [Abstract] [Full Text] [Related]

  • 18. An essential part for Rho-associated kinase in the transcellular invasion of tumor cells.
    Itoh K, Yoshioka K, Akedo H, Uehata M, Ishizaki T, Narumiya S.
    Nat Med; 1999 Feb 01; 5(2):221-5. PubMed ID: 9930872
    [Abstract] [Full Text] [Related]

  • 19. Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction.
    Nagatoya K, Moriyama T, Kawada N, Takeji M, Oseto S, Murozono T, Ando A, Imai E, Hori M.
    Kidney Int; 2002 May 01; 61(5):1684-95. PubMed ID: 11967018
    [Abstract] [Full Text] [Related]

  • 20. Rho-dependent, Rho kinase-independent inhibitory regulation of Rac and cell migration by LPA1 receptor in Gi-inactivated CHO cells.
    Sugimoto N, Takuwa N, Yoshioka K, Takuwa Y.
    Exp Cell Res; 2006 Jun 10; 312(10):1899-908. PubMed ID: 16564043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.